Literature DB >> 23437985

Livedoid vasculopathy - current aspects of diagnosis and treatment of cutaneous infarction.

Nina Kerk1, Tobias Goerge.   

Abstract

Livedoid vasculopathy is a rare, chronic, recurrent disease of the cutaneous microcirculation. Its typical clinical manifestation is a triad which consists of livedo racemosa of the skin, episodic painful ulcerations of the distal aspects of the legs and a healing process leaving small porcelain-white scars called atrophie blanche. As an important result of recent research, livedoid vasculopathy has been defined as a coagulation disorder classified as a vasculopathy different from inflammatory vasculitis. This differentiation adds to the current pathophysiologic understanding and supports the therapeutic rationale with respect to the use of new systemic anticoagulants. The prevention of irreversible residual scarring and the improvement of patientsí quality of life are the main goals in treating cutaneous infarction and require early and consequent treatment. This article presents current knowledge on diagnosing this rare disease and offers practical guidance on its therapy.
© The Authors • Journal compilation © Blackwell Verlag GmbH, Berlin.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23437985     DOI: 10.1111/ddg.12064

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  10 in total

Review 1.  [Chronic leg ulcers].

Authors:  J Dissemond
Journal:  Hautarzt       Date:  2017-08       Impact factor: 0.751

2.  Juvenile primary Sjogren's syndrome with cutaneous involvement.

Authors:  Songwei He; Xiaofang Zhen; Yan Hu
Journal:  Clin Rheumatol       Date:  2021-03-12       Impact factor: 2.980

3.  Plasminogen activator inhibitor-1: a potential etiological role in livedoid vasculopathy.

Authors:  Yimeng Gao; Hongzhong Jin
Journal:  Int Wound J       Date:  2020-10-11       Impact factor: 3.315

4.  Fast Cicatrization of Extensive Livedoid Vasculopathy Ulcers under Treatment with Sildenafil.

Authors:  Lediane Moreira Lopes; Guilherme Gomes Dias Campos; Matheus Augusto Eisenreich; Aline Defaveri do Prado; Markus Bredemeier
Journal:  Ann Dermatol       Date:  2017-02-03       Impact factor: 1.444

5.  Treatment application of rivaroxaban in Chinese patients with livedoid vasculopathy.

Authors:  Wenji Chen; Lina Fan; Yanyan Wang; Xiaohu Deng
Journal:  J Pain Res       Date:  2017-03-17       Impact factor: 3.133

6.  Dermoscopic features of livedoid vasculopathy.

Authors:  Stephen Chu-Sung Hu; Gwo-Shing Chen; Chi-Ling Lin; Yang-Chun Cheng; Yung-Song Lin
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

7.  Atypical Mycobacterial Infection Arising Amid Corticosteroid Therapy for Livedoid Vasculopathy.

Authors:  John R Edminister; Nicole Dominiak; Lorie D Gottwald
Journal:  Case Rep Dermatol Med       Date:  2019-10-07

Review 8.  Bar code reader - an algorithmic approach to cutaneous occluding vasculopathies? Part I: small vessel vasculopathies.

Authors:  Gudrun Ratzinger; Bettina G Zelger; Bernhard W Zelger
Journal:  J Dtsch Dermatol Ges       Date:  2019-09-05       Impact factor: 5.584

9.  Intravenous Immunoglobulin Therapy in Livedoid Vasculopathy: Retrospective Observation of Clinical Outcome and Patient's Activity Level.

Authors:  Katrin Kofler; Anke Strölin; Vanessa Geiger; Lukas Kofler
Journal:  J Cutan Med Surg       Date:  2021-03-28       Impact factor: 2.092

Review 10.  Comparative Efficacy of Rivaroxaban and Immunoglobulin Therapy in the Treatment of Livedoid Vasculopathy: A Systematic Review.

Authors:  Shivana Ramphall; Swarnima Rijal; Vishakh Prakash; Heba Ekladios; Jiya Mulayamkuzhiyil Saju; Naishal Mandal; Nang I Kham; Rabia Shahid; Shaili S Naik; Sathish Venugopal
Journal:  Cureus       Date:  2022-08-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.